RVMD - Revolution Medicines, Inc.
99.64
-1.550 -1.556%
Share volume: 1,704,583
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$101.19
-1.55
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-07-2024 | 11-06-2024 | 02-26-2025 | 05-07-2025 | 11-05-2025 | 02-25-2026 | |
| Assets | ||||||||
| Total Assets | 1.908 B | 1.808 B | 1.763 B | 2.558 B | 2.365 B | 2.252 B | 2.355 B | |
| Current Assets | 1.729 B | 1.625 B | 1.579 B | 2.328 B | 2.135 B | 1.977 B | 2.075 B | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 25.662 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 25.662 M | 1.315 B | 1.348 B | 1.746 B | 1.769 B | 1.714 B | 1.642 B | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.704 B | 275.713 M | 201.262 M | 543.064 M | 333.554 M | 217.442 M | 383.745 M | |
| Total Non-current Assets | 179.160 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 23.697 M | 25.284 M | 24.814 M | 24.289 M | 27.153 M | 32.926 M | 33.194 M | |
| Other Assets | 80.352 M | 158.423 M | 159.046 M | 206.380 M | 203.618 M | 224.654 M | 246.277 M | |
| Intangible Assets | 57.472 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 14.608 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 1.908 B | 1.808 B | 1.763 B | 2.558 B | 2.365 B | 2.252 B | 2.355 B | |
| Total liabilities | 182.895 M | 189.589 M | 196.695 M | 293.097 M | 287.203 M | 655.016 M | 723.211 M | |
| Total current liabilities | 93.723 M | 105.332 M | 110.863 M | 163.914 M | 158.599 M | 245.622 M | 290.424 M | |
| Accounts Payable | 32.379 M | 29.319 M | 24.456 M | 54.427 M | 47.507 M | 74.849 M | 64.616 M | |
| Other liabilities | 6.197 M | 81.142 M | 82.717 M | 126.830 M | 126.251 M | 407.041 M | 430.434 M | |
| Current long term debt | 8.169 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 79.860 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 6.197 M | 81.142 M | 82.717 M | 126.830 M | 126.251 M | 407.041 M | 430.434 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.725 B | 1.619 B | 1.566 B | 2.265 B | 2.078 B | 1.597 B | 1.631 B | |
| Common stock | 164.729 M | 3.008 B | 3.106 B | 4.002 B | 4.028 B | 4.098 B | 4.497 B | |
| Retained earnings | -1.254 B | -1.387 B | -1.543 B | -1.738 B | -1.951 B | -2.504 B | -2.869 B |